Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genetic SignaturesASX:GSS -1.49% Days Inventory is 367.84 as of Dec. 2025, which is 1% above its 10-year median of 362.85. The stock has 4 warning signs investors should review. Among 179 Medical Diagnostics & Research companies, Genetic Signatures ranks worse than 93.3% on this metric.
The historical rank and industry rank for Genetic Signatures's Days Inventory or its related term are showing as below:
ASX:GSS'
s Days Inventory Range Over the Past 10 Years
Min: 274.4 Med: 362.85 Max: 517.41
Current: 353.08
During the past 11 years, Genetic Signatures's highest Days Inventory was 517.41. The lowest was 274.40. And the median was 362.85.
ASX:GSS's Days Inventory is ranked worse than 93.3% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.04
vs ASX:GSS: 353.08
Genetic Signatures's Days Inventory
increased
from Dec. 2024 (315.71) to Dec. 2025 (367.84).
It might indicate that Genetic Signatures's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Genetic Signatures's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genetic Signatures's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.01.
Genetic Signatures (ASX:GSS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Genetic Signatures's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genetic Signatures's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Genetic Signatures Days Inventory Related Terms
Genetic Signatures Days Inventory Historical Data
* Premium members only.
The historical data trend for Genetic Signatures's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:GSS vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Genetic Signatures's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetic Signatures Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Days Inventory distribution charts can be found below:
* The bar in red indicates where Genetic Signatures's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetic Signatures (ASX:GSS) has a Days Inventory of 367.84 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genetic Signatures and its competitors. This is near median its historical median of 362.85. Over the past decade, Genetic Signatures' Days Inventory has ranged from 274.40 to 517.41. According to the industry distribution chart, Genetic Signatures ranks #167 out of 179 companies in the Medical Diagnostics & Research industry, placing it in the top 93.3%.
Is Genetic Signatures' Days Inventory too high?
Genetic Signatures' current Days Inventory of 367.84 is near median its 10-year median of 362.85. Over the past 10 years, this metric has ranged from a low of 274.40 to a high of 517.41. The Medical Diagnostics & Research industry median Days Inventory is 65.04. Genetic Signatures' value of 367.84 is 465.6% above this industry median. Based on the distribution chart, Genetic Signatures ranks #167 out of 179 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Genetic Signatures' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Genetic Signatures ranks #167 out of 179 companies for Days Inventory. This places Genetic Signatures in the lower half of its industry. The industry median Days Inventory is 65.04. Genetic Signatures' value of 367.84 is 465.6% above this benchmark. Historically, Genetic Signatures' own Days Inventory has ranged from 274.40 to 517.41 over the past decade. While the company's 10-year median is 362.85 vs. the industry median of 65.04, Genetic Signatures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 65.04, based on 179 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genetic Signatures's current Days Inventory of 367.84 is 465.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genetic Signatures and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 65.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetic Signatures's current Days Inventory is 367.84, which is near median its own 10-year median of 362.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Signatures stock overvalued right now?
Based on GuruFocus' analysis, Genetic Signatures (ASX:GSS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.38, compared to a current price of A$0.07 — trading 82.6% below its estimated fair value. The current Days Inventory is 367.84, which is near median its 10-year median of 362.85 and 465.6% above the Medical Diagnostics & Research industry median of 65.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Genetic Signatures (ASX:GSS), the current Days Inventory is 367.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GSS has been successfully added to your 
